Sustained Therapeutics
PrivateLast Round
Accelerator
Oct 1, 2020
Momentum Score
50 /100
Company Overview
Sustained Therapeutics is a pharmaceutical company that develops a patented sustained-release platform designed to deliver approved drugs for unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sustained Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Sustained Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 1, 2020 | ||||
| Accelerator | Jan 1, 2020 |
Key People
Founding team and executive leadership
Sustained Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
| The University of British Columbia | Accelerator |
| HATCH Venture Builder | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 220% MoM.
- Jun 1, 2025
Monthly visitors grew 440% MoM, from 611 to 3.3K.
Sustained Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sustained Therapeutics's valuation, stock price, and market status.